Molecular Therapy of Melanocortin-4-Receptor Obesity by an Autoregulatory BDNF Vector
Mutations in the melanocortin-4-receptor (MC4R) comprise the most common monogenic form of severe early-onset obesity, and conventional treatments are either ineffective long-term or contraindicated. Immediately downstream of MC4R—in the pathway for regulating energy balance—is brain-derived neurotr...
Main Authors: | Jason J. Siu, Nicholas J. Queen, Xianglan Liu, Wei Huang, Travis McMurphy, Lei Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050117301043 |
Similar Items
-
Hypothalamic Gene Therapy by an Autoregulatory BDNF Vector to Prevent Melanocortin-4-Receptor-Deficient Obesity
by: Siu, Jason J., Siu
Published: (2018) -
The melanocortin pathway and energy homeostasis: From discovery to obesity therapy
by: Giles S.H. Yeo, et al.
Published: (2021-06-01) -
Neuroanatomy of melanocortin-4 receptor pathway in the mouse brain
by: Wang Kun, et al.
Published: (2020-08-01) -
Melanocortins, Melanocortin Receptors and Multiple Sclerosis
by: Robert P. Lisak, et al.
Published: (2017-08-01) -
Melanocortin Regulation of Inflammation
by: Wei Wang, et al.
Published: (2019-10-01)